CYP51 as drug targets for fungi and protozoan parasites: past, present and future
GI Lepesheva, L Friggeri, MR Waterman - Parasitology, 2018 - cambridge.org
The efficiency of treatment of human infections with the unicellular eukaryotic pathogens
such as fungi and protozoa remains deeply unsatisfactory. For example, the mortality rates …
such as fungi and protozoa remains deeply unsatisfactory. For example, the mortality rates …
Antioxidant, antimicrobial, antiparasitic, and cytotoxic properties of various Brazilian propolis extracts
RP Dantas Silva, BAS Machado, GA Barreto, SS Costa… - Plos one, 2017 - journals.plos.org
Propolis is known for its biological properties and its preparations have been continuously
investigated in an attempt to solve the problem of their standardization, an issue that limits …
investigated in an attempt to solve the problem of their standardization, an issue that limits …
Tailoring NO donors metallopharmaceuticals: ruthenium nitrosyl ammines and aliphatic tetraazamacrocycles
E Tfouni, FG Doro, LE Figueiredo… - Current medicinal …, 2010 - ingentaconnect.com
The discovery of the involvement of nitric oxide (NO) in several physiological and
pathophysiological processes launched a spectacular increase in studies in areas such as …
pathophysiological processes launched a spectacular increase in studies in areas such as …
In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
AMC Canavaci, JM Bustamante… - PLoS neglected …, 2010 - journals.plos.org
Background The two available drugs for treatment of T. cruzi infection, nifurtimox and
benznidazole (BZ), have potential toxic side effects and variable efficacy, contributing to their …
benznidazole (BZ), have potential toxic side effects and variable efficacy, contributing to their …
Intra-host Trypanosoma cruzi strain dynamics shape disease progression: the missing link in Chagas disease pathogenesis
E Dumonteil, H Desale, W Tu… - Microbiology …, 2023 - Am Soc Microbiol
Chronic Chagasic cardiomyopathy develops years after infection in 20–40% of patients, but
disease progression is poorly understood. Here, we assessed Trypanosoma cruzi parasite …
disease progression is poorly understood. Here, we assessed Trypanosoma cruzi parasite …
Trypanosoma cruzi response to the oxidative stress generated by hydrogen peroxide
JK Finzi, CWM Chiavegatto, KF Corat, JA Lopez… - Molecular and …, 2004 - Elsevier
As an intracellular parasite, Trypanosoma cruzi is exposed to reactive oxygen species. The
study of the proteins involved in the hydroperoxide detoxification cascade, tryparedoxin …
study of the proteins involved in the hydroperoxide detoxification cascade, tryparedoxin …
Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi
We describe herein an evaluation of trypanocidal effects of the natural alkaloid piperine and
twelve synthetic derivatives against epimastigote and amastigote forms of the protozoan …
twelve synthetic derivatives against epimastigote and amastigote forms of the protozoan …
In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors
JJN Silva, AL Osakabe, WR Pavanelli… - British journal of …, 2007 - Wiley Online Library
Background and purpose: Many compounds liberating NO (NO donors) have been used as
therapeutic agents. Here we test two ruthenium nitrosyls, which release NO when activated …
therapeutic agents. Here we test two ruthenium nitrosyls, which release NO when activated …
Applicability of plant-based products in the treatment of Trypanosoma cruzi and Trypanosoma brucei infections: a systematic review of preclinical in vivo evidence
RM Pereira, GMZ Greco, AM Moreira, PF Chagas… - Parasitology, 2017 - cambridge.org
Chagas disease and sleeping sickness are neglected tropical diseases closely related to
poverty, for which the development of plant-derived treatments has not been a promising …
poverty, for which the development of plant-derived treatments has not been a promising …
In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi
J Saraiva, C Vega, M Rolon, R da Silva… - Parasitology …, 2007 - Springer
The trypanocidal effect of six lignan lactones,(−)-cubebin (1),(−)-O-methyl cubebin (2),(−)-O-
benzyl cubebin (3),(−)-6, 6′-dinitrohinokinin (4),(−)-hinokinin (5) and dimethoxymorelensin …
benzyl cubebin (3),(−)-6, 6′-dinitrohinokinin (4),(−)-hinokinin (5) and dimethoxymorelensin …